Drug Testing Locations - Westland, PA

Drug Testing in Westland, PA

Westland, Pennsylvania Statistics

In 2022, Washington County, including Westland, reported a 15% rise in opioid-related overdoses.

Washington County's 2021 data showed that fentanyl was involved in 70% of drug-related deaths.

In Westland, PA, substance abuse treatment admissions rose by 25% from 2019 to 2021.

The 2020 reports highlighted that 65% of drug-related arrests in Washington County were related to heroin and methamphetamine.

In 2021, Washington County authorities seized over 200 pounds of illicit drugs, marking a 30% increase from 2020.

Westland's Narcan administration incidents doubled in 2021 compared to the previous year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Westland, PA & Drug Testing Policies

Employers in Westland, PA, are increasingly adopting strict drug testing policies to ensure workplace safety and productivity. Many companies align their policies with guidelines provided by the Substance Abuse and Mental Health Services Administration (SAMHSA).

The economic landscape of Washington County necessitates vigilant measures against drug abuse in the workforce. Employers often conduct pre-employment screening and random drug tests to deter substance abuse and prevent related incidents.

Organizations collaborate with local health services to offer Employee Assistance Programs (EAPs), supporting employees who may struggle with addiction and facilitating their access to treatment resources.

Government Efforts with Drug Problems in Westland, PA

The government of Washington County, where Westland, PA is located, has implemented various initiatives to tackle drug issues. Programs funded by the Pennsylvania Department of Drug and Alcohol Programs aim to enhance prevention and treatment services.

Local efforts in Westland include community outreach and education campaigns to reduce stigma and encourage help-seeking behaviors. The county collaborates with organizations like the U.S. Department of Health & Human Services to provide resources and training for first responders.

Local Drug Busts & News in Westland, PA

In recent years, Westland, PA, has witnessed significant drug busts as part of efforts to curb illegal distribution. In 2020, a multi-agency operation in Washington County resulted in the arrest of a major drug trafficking network involving heroin and methamphetamine.

The increase in overdose rates has prompted local law enforcement to focus on disrupting supply chains. Collaborative efforts with state and federal agencies have led to substantial seizures of illicit substances and arrests of key figures in the drug trade.

Community awareness events and partnerships with local organizations have been vital in identifying issues and taking proactive measures against drug-related problems in Westland.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Westland, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

PA Department of Drug and Alcohol Programs

SAMHSA

County Drug and Alcohol Offices

HHS o-drug Initiative

Office of National Drug Control Policy

OverdoseFreePA

Recovery Resources in PA

Where and When (PA Meetings Directory)

Narcotics Anonymous

Alcoholics Anonymous

Drug Testing Near Westland, PA

Wolfdale, PA

Murry Hill, PA

Bishop, PA

Cecil-Bishop, PA

Cowden, PA

Woodrow, PA

Meadow Lands, PA

Canonsburg, PA

Cecil, PA

Meadowlands, PA

McGovern, PA

Strabane, PA

Moninger, PA

Muse, PA

Southview, PA

Frequently Asked Questions

Customer Reviews